Entera Bio Ltd.
ENTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001638097
No open-market purchases or sales by Entera Bio Ltd. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $19.0M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Entera Bio Ltd. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- +6 vs. Q1 2021
- Shares held
- 5.11M
- +3.13M (+157.4%) vs. Q1 2021
- Total value
- $30.6M
- +$23.0M (+303.9%) vs. Q1 2021
- New holders
- 9
- 1 more added
- Sold out
- 3
- 4 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $19.0M |
| Q1 2026 | 26 | $8.68M |
| Q4 2025 | 22 | $18.1M |
| Q3 2025 | 22 | $17.7M |
| Q2 2025 | 19 | $19.4M |
| Q1 2025 | 18 | $17.4M |
| Q4 2024 | 14 | $15.9M |
| Q3 2024 | 17 | $10.1M |
| Q2 2024 | 15 | $9.75M |
| Q1 2024 | 15 | $7.11M |
| Q4 2023 | 10 | $2.44M |
| Q3 2023 | 12 | $1.87M |
| Q2 2023 | 12 | $2.17M |
| Q1 2023 | 9 | $3.28M |
| Q4 2022 | 12 | $415.9K |
| Q3 2022 | 9 | $4.85M |
| Q2 2022 | 10 | $6.54M |
| Q1 2022 | 12 | $14.2M |
| Q4 2021 | 12 | $15.9M |
| Q3 2021 | 14 | $26.7M |
| Q2 2021 | 14 | $30.6M |
| Q1 2021 | 8 | $7.57M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Entera Bio Ltd.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 1,022 | $6.00K | 0.00% | −592−36.7% | Reduced |
| Morgan Stanley | 2,190 | $13.0K | 0.00% | +2,190 | New |
| Cutler Group LP | 4,600 | $27.0K | 0.00% | +4,600 | New |
| Tower Research Capital LLC (TRC) | 9,008 | $54.0K | 0.00% | −12,991−59.1% | Reduced |
| XTX Topco Ltd | 10,433 | $62.0K | 0.02% | −1,126−9.7% | Reduced |
| Susquehanna Fundamental Investments, LLC | 14,400 | $86.0K | 0.00% | +14,400 | New |
| Simplex Trading, LLC | 15,742 | $94.0K | 0.00% | +15,742 | New |
| Geode Capital Management, LLC | 17,597 | $105.0K | 0.00% | +17,597 | New |
| Verition Fund Management LLC | 30,523 | $183.0K | 0.00% | +30,523 | New |
| Millennium Management LLC | 34,775 | $208.0K | 0.00% | −3,836−9.9% | Reduced |
| Susquehanna International Group, LLP | 66,733 | $399.0K | 0.00% | +66,733 | New |
| Citadel Advisors LLC | 67,170 | $402.0K | 0.00% | +67,170 | New |
| Ra Capital Management, L.P. | 2,353,000 | $14.1M | 0.23% | +2,353,000 | New |
| Knoll Capital Management, LLC | 2,484,275 | $14.9M | 7.76% | +692,912+38.7% | Added |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −120,407−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −100−100.0% | Sold out |